Dr. Sita Somara is the founder and CEO of Soma Life Science Solutions and is a seasoned biopharmaceutical professional with over 15 years of experience in drug development, regulatory strategy, and international business. A visionary leader, Dr. Somara has a proven track record of advancing innovative therapies, successfully leading cross-functional teams in the development of small molecules, biologics, and regenerative medicine, including pioneering work in cell and gene therapies. Her expertise has been instrumental in securing Investigational New Drug (IND) approvals, effectively streamlining the path from concept to market.

Passionate about integrating cutting-edge technologies, Dr. Somara focuses on harnessing artificial intelligence (AI) to enhance drug development and regulatory processes. By leveraging AI-driven insights, she aims to improve decision-making, drug development process, optimize regulatory submissions, and accelerate clinical trial designs, ultimately expediting the approval of life-saving therapies and shaping the future of healthcare.

In addition to her professional achievements, Dr. Somara is dedicated to advancing regenerative medicine and fostering a vibrant community of providers, advocates, and supporters. Through her non-profit organization, Regenerative Med Therapy, she is building a comprehensive resource hub to showcase how regenerative medicine therapies can transform patient outcomes and restore quality of life. Driven by a commitment to positive change, Dr. Somara is focused on creating healthier, more vibrant societies both locally and globally.